Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

  • Professor of Pharmacy, Therapeutics, and Critical Care Medicine
  • Director, Pharmacy Resident Research Series, UPMC/University of Pittsburgh
  • Lead, Area of Concentration, Pharmacoanalytcis for Doctorate of Pharmacy Program Students

    Education & Training

  • Bachelor of Science, Pharmacy, Wayne State University, 1994
  • ASHP-Accredited Pharmacy Practice, West Virginia University Hospital, 1995-1996
  • Doctorate of Pharmacy, University of Toledo, 1996-1998
  • Masters of Science, Pharmacy Administration, The Ohio State University, 1999-2001
  • Critical Care Fellowship, The Ohio State University, 1999-2001
  • Certificate in Implementation Science, University of California, San Francisco, 2018-2019
American Society of Health-System Pharmacist (ASHP) Residency Excellence Award- Preceptor, 2016
Pennsylvania Pharmacists Association Excellence in Innovation Award, 2019
West Virginia University Hospitals, Commitment to Pharmacy Excellence Award, 2019
American Society of Health-System Pharmacist (ASHP) Literature Award for Sustained Contributions, 2021
Representative Publications

Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, George EL, Pohlman AS, Agarwal S, Henneman EA, Bejian SM. Clinical practice guideline: safe medication use in the ICU. Critical care medicine. 2017 Sep 1;45(9):e877-915.

Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nature Reviews Nephrology. 2017 Apr;13(4):241-57.

Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, Kane-Gill SL, Liu KD, Prowle JR, Shaw AD, Srisawat N. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney international. 2020 Aug 1;98(2):294-309.

Kane-Gill SL. Nephrotoxin Stewardship. Critical Care Clinics. 2021 Feb 13.

A full list of over 200 publications can be found here.

Research Interests
  • Applied health services research enabling better care decisions of drug therapy for critically ill patients by evaluating clinical, economic and humanistic factors.
  • Building a pharmacovigilance program to improve quality of care and patient safety, often with tools such as clinical decision support, with particular emphasis on nephrotoxin stewardship and drug associated acute kidney injury.
  • Using implementation science to ensure adopton of best practices resulting in optimal patient care and patient safety.